嚢胞性線維症向け気道確保デバイス：市場洞察・競合情勢・市場予測 (～2032年)

嚢胞性線維症向け気道確保デバイスの市場規模は、予測期間中はCAGR 5.03％で成長すると予測されています。

嚢胞性線維症向け気道確保デバイスの需要は、嚢胞性線維症の有病率の増加、遺伝性疾患の症例の増加、研究開発活動の増加、主要企業間の研究協力などによって促進されています。

嚢胞性線維症向け気道確保デバイスの市場力学：

英国議会が2023年1月に発表した報告書によると、英国では2023年に約1万800人が嚢胞性線維症を患っているとされています。2024年5月のVertex Pharmaceuticals Incorporatedの発表によると、世界では9万2,000人が嚢胞性線維症と診断されていると推定されています。気道確保デバイスは、気道壁をクリアにすることで嚢胞性線維症の管理に役立つため、嚢胞性線維症の有病率の上昇が市場成長を促進すると予想されています。

市場の主要企業は、病院や在宅医療用途の気道確保デバイスの開発と商品化に力を注いでいます。主要企業による研究開発活動の活発化が、嚢胞性線維症向け気道確保デバイスの市場成長を後押ししています。

デバイスタイプ別では、高周波胸壁振動デバイスの部門が2024年に最大の収益シェアを占めると推計されています。高周波胸壁振動デバイスは、胸壁の機械的振動または振動を利用して、気道に蓄積した粘液の排出を助け、粘液の緩みと動員を促進します。このデバイスは、気道壁からの痰や粘液の除去を必要とする慢性肺疾患の治療にも使用されます。

地域別では、北米が2024年に圧倒的な市場シェアを示すと予想されています。これは、同地域で嚢胞性線維症の有病率が増加しているためです。

当レポートでは、世界の嚢胞性線維症向け気道確保デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 嚢胞性線維症向け気道確保デバイス市場レポート：イントロダクション

• 調査範囲
• 市場セグメンテーション
• 市場の前提因子

第2章 嚢胞性線維症向け気道確保デバイス市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 嚢胞性線維症向け気道確保デバイス市場：主要要因分析

• 市場促進要因
  • 嚢胞性線維症の罹患率の増加
  • 遺伝性疾患の増加
  • 主要企業間の研究開発活動と研究協力の拡大
• 市場抑制要因と課題
  • 気道確保デバイスに関連する合併症
  • 製品リコール
• 市場機会
  • 在宅ケア環境へのデジタルヘルスの統合
  • AIを活用した気道確保デバイスの登場

第6章 嚢胞性線維症向け気道確保デバイス市場：ポーターのファイブフォース分析

第7章 嚢胞性線維症向け気道確保デバイス市場の評価

• デバイスタイプ別
  • 高周波胸壁振動デバイス
  • 呼気陽圧デバイス
  • メカニカルパーカッション (MP) デバイス
  • その他
• エンドユーザー別
  • 病院・診療所
  • 在宅医療
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 嚢胞性線維症向け気道確保デバイス市場：企業・製品プロファイル

• Baxter
• Koninklijke Philips N.V.
• Electromed, Inc.
• ICU Medical, Inc.
• Trudell Medical International
• CEGLA Medizintechnik GmbH
• PARI GmbH
• Monaghan
• VORTRAN Medical Technology 1 Inc.
• Tactile Medical
• Mercury Medical
• Med Systems, Inc.
• Vyaire Medical, Inc.
• Synchrony Medical
• Dymedso
• SunMed LLCWestmed, Inc.
• RespInnovation
• Inogen, Inc.
• Thayer Medical
• Medline Industries, LP

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Airway Clearance Devices For Cystic Fibrosis Market in Global (2022-2032)
• Table 3: Airway Clearance Devices For Cystic Fibrosis Market in Global by Device Type (2022-2032)
• Table 4: Airway Clearance Devices For Cystic Fibrosis Market in Global by End-User (2022-2032)
• Table 5: Airway Clearance Devices For Cystic Fibrosis Market in Global by Geography (2022-2032)
• Table 6: Airway Clearance Devices For Cystic Fibrosis Market in North America (2022-2032)
• Table 7: Airway Clearance Devices For Cystic Fibrosis Market in the US (2022-2032)
• Table 8: Airway Clearance Devices For Cystic Fibrosis Market in Canada (2022-2032)
• Table 9: Airway Clearance Devices For Cystic Fibrosis Market in Mexico (2022-2032)
• Table 10: Airway Clearance Devices For Cystic Fibrosis Market in Europe (2022-2032)
• Table 11: Airway Clearance Devices For Cystic Fibrosis Market in France (2022-2032)
• Table 12: Airway Clearance Devices For Cystic Fibrosis Market in Germany (2022-2032)
• Table 13: Airway Clearance Devices For Cystic Fibrosis Market in the United Kingdom (2022-2032)
• Table 14: Airway Clearance Devices For Cystic Fibrosis Market in Italy (2022-2032)
• Table 15: Airway Clearance Devices For Cystic Fibrosis Market in Spain (2022-2032)
• Table 16: Airway Clearance Devices For Cystic Fibrosis Market in Rest of Europe (2022-2032)
• Table 17: Airway Clearance Devices For Cystic Fibrosis Market in Asia-Pacific (2022-2032)
• Table 18: Airway Clearance Devices For Cystic Fibrosis Market in China (2022-2032)
• Table 19: Airway Clearance Devices For Cystic Fibrosis Market in Japan (2022-2032)
• Table 20: Airway Clearance Devices For Cystic Fibrosis Market in India (2022-2032)
• Table 21: Airway Clearance Devices For Cystic Fibrosis Market in Australia (2022-2032)
• Table 22: Airway Clearance Devices For Cystic Fibrosis Market in South Korea (2022-2032)
• Table 23: Airway Clearance Devices For Cystic Fibrosis Market in Rest of Asia-Pacific (2022-2032)
• Table 24: Airway Clearance Devices For Cystic Fibrosis Market in Rest of the World (2022-2032)
• Table 25: Airway Clearance Devices For Cystic Fibrosis Market in the Middle East (2022-2032)
• Table 26: Airway Clearance Devices For Cystic Fibrosis Market in Africa (2022-2032)
• Table 27: Airway Clearance Devices For Cystic Fibrosis Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Airway Clearance Devices For Cystic Fibrosis Market in Global (2022-2032)
• Figure 3: Airway Clearance Devices For Cystic Fibrosis Market in Global by Device Type (2022-2032)
• Figure 4: Airway Clearance Devices For Cystic Fibrosis Market in Global by End-User (2022-2032)
• Figure 5: Airway Clearance Devices For Cystic Fibrosis Market in Global by Geography (2022-2032)
• Figure 6: Airway Clearance Devices For Cystic Fibrosis Market in North America (2022-2032)
• Figure 7: Airway Clearance Devices For Cystic Fibrosis Market in the US (2022-2032)
• Figure 8: Airway Clearance Devices For Cystic Fibrosis Market in Canada (2022-2032)
• Figure 9: Airway Clearance Devices For Cystic Fibrosis Market in Mexico (2022-2032)
• Figure 10: Airway Clearance Devices For Cystic Fibrosis Market in Europe (2022-2032)
• Figure 11: Airway Clearance Devices For Cystic Fibrosis Market in France (2022-2032)
• Figure 12: Airway Clearance Devices For Cystic Fibrosis Market in Germany (2022-2032)
• Figure 13: Airway Clearance Devices For Cystic Fibrosis Market in the United Kingdom (2022-2032)
• Figure 14: Airway Clearance Devices For Cystic Fibrosis Market in Italy (2022-2032)
• Figure 15: Airway Clearance Devices For Cystic Fibrosis Market in Spain (2022-2032)
• Figure 16: Airway Clearance Devices For Cystic Fibrosis Market in Rest of Europe (2022-2032)
• Figure 17: Airway Clearance Devices For Cystic Fibrosis Market in Asia-Pacific (2022-2032)
• Figure 18: Airway Clearance Devices For Cystic Fibrosis Market in China (2022-2032)
• Figure 19: Airway Clearance Devices For Cystic Fibrosis Market in Japan (2022-2032)
• Figure 20: Airway Clearance Devices For Cystic Fibrosis Market in India (2022-2032)
• Figure 21: Airway Clearance Devices For Cystic Fibrosis Market in Australia (2022-2032)
• Figure 22: Airway Clearance Devices For Cystic Fibrosis Market in South Korea (2022-2032)
• Figure 23: Airway Clearance Devices For Cystic Fibrosis Market in Rest of Asia-Pacific (2022-2032)
• Figure 24: Airway Clearance Devices For Cystic Fibrosis Market in Rest of the World (2022-2032)
• Figure 25: Airway Clearance Devices For Cystic Fibrosis Market in the Middle East (2022-2032)
• Figure 26: Airway Clearance Devices For Cystic Fibrosis Market in Africa (2022-2032)
• Figure 27: Airway Clearance Devices For Cystic Fibrosis Market in South America (2022-2032)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of cystic fibrosis and respiratory disorders and rising incidence of genetic diseases

The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032. The demand for airway clearance devices for cystic fibrosis is primarily driven by the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, and research collaboration among key players are some of the key factors responsible for contributing to the positive growth of airway clearance devices for the cystic fibrosis market during the forecast period from 2025 to 2032.

Airway Clearance Devices for Cystic Fibrosis Market Dynamics:

The airway clearance devices are created based on physiological principles that work by creating resistance and vibration that help to loosen and clear mucous from airway walls to enhance sputum clearance. According to a report published by the UK Parliament in January 2023, stated that approximately 10,800 people were living with cystic fibrosis in 2023 in the United Kingdom. According to Vertex Pharmaceuticals Incorporated in May 2024, it was estimated that 92,000 people were diagnosed with cystic fibrosis across the globe. Airway clearance devices help to manage cystic fibrosis by clearing the airway walls, thus, the rising prevalence of cystic fibrosis is expected to drive the market growth.

Cystic fibrosis is a genetic condition caused by gene abnormality that causes the production of abnormally thick and sticky liquid called mucous. According to NHS England in February 2024, approximately 3.5 million people were affected by genetic diseases in 2021 in the United Kingdom and this number comprises 1 in 17 people being affected by a rare disease. Therefore, the rising occurrence of rare genetic diseases contributes to increased cases of cystic fibrosis which is contributing to the growth of the market.

Key players in the market are concentrating their efforts on developing and commercializing airway clearance devices for hospital and home healthcare applications. For instance, in December 2022, ABM Respiratory Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze(R) Clear System. This airway clearance system helps patients clear their airways as well as prevent or treat cystic fibrosis by using oscillating lung expansion (OLE) therapy. Therefore, the increasing research and development activities by key players are driving the growth of airway clearance devices for the cystic fibrosis market.

However, the complications associated with airway clearance devices, and product recalls, among others are some of the key constraints that may hinder the growth of airway clearance devices for the cystic fibrosis market.

Airway Clearance Devices for Cystic Fibrosis Market Segment Analysis:

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of airway clearance devices for the cystic fibrosis market, the high-frequency chest wall oscillation device category is estimated to hold the largest revenue share in the airway clearance devices for the cystic fibrosis market in 2024. High-frequency chest wall oscillation devices use mechanical oscillations or vibrations on the chest wall to aid in the clearance of accumulated mucus from the airways, facilitating its loosening and mobilization. This device is also used for the treatment of chronic lung diseases which require clearance of sputum and mucous from airway walls.

Key players in the market are developing advanced devices for the management of cystic fibrosis and other disease that require devices for airway clearances. For instance, in November 2022, Electromed, Inc. announced that it received U.S Food and Drug Administration 510(k) clearance for the SmartVest(R) Clearway(R) Airway Clearance System, which is designed for High-Frequency Chest Wall Oscillation therapy. This device works by delivering alternating pulses of air into a vest, causing rapid compression and release of the chest wall. This process generates airflow oscillations within the airways, which serve to loosen, thin, and propel mucus towards the larger airways for easier expectoration.

Therefore, the growing use of high-frequency chest wall oscillation devices in cystic fibrosis is expected to contribute to the growth of the segment, thereby driving the growth of the airway clearance devices for the cystic fibrosis market during the forecast period.

North America is expected to dominate the overall Airway Clearance Devices for Cystic Fibrosis Market:

North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. The rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.

Air clearance devices mechanically conducts chest physical therapy through high-frequency vibrations. The vest vibrates the chest to help loosen and thin thick, sticky mucus commonly found in cystic fibrosis. According to data published by Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35,000 peoples were suffering with cystic fibrosis in 2024 in the United States. Therefore, the rising cases of cystic fibrosis is expected to drive the market growth in North America.

Airway Clearance Devices for Cystic Fibrosis Market Key Players:

Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

Recent Developmental Activities in the Airway Clearance Devices for Cystic Fibrosis Market:

• In September 2023, Inogen, Inc. completed the acquisition of Physio-Assist SAS. Through this acquisition, Inogen acquired Simeox from Physio-Assist which is a technology-enabled airway clearance and mucus management device for treatment of cystic fibrosis.
• In September 2021, Tactile Medical completed acquisition of AffloVest respiratory therapy business from International Biophysics Corporation. This acquisition strengthened the position of Tactile Medical in cystic fibrosis treatment market and increased its product portfolio and global presence.

Key Takeaways from the Airway Clearance Devices for Cystic Fibrosis Market Report Study

• Market size analysis for current Airway Clearance Devices For Cystic Fibrosis Market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Airway Clearance Devices for Cystic Fibrosis market.
• Various opportunities available for the other competitors in the Airway Clearance Devices for Cystic Fibrosis Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Airway Clearance Devices for Cystic Fibrosis market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Airway Clearance Devices for Cystic Fibrosis market growth in the coming future?

Target Audience who can be benefited from this Airway Clearance Devices for Cystic Fibrosis Market Report Study

• Airway Clearance Devices For Cystic Fibrosis product providers
• Research organizations and consulting companies
• Airway Clearance Devices For Cystic Fibrosis related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Airway Clearance Devices For Cystic Fibrosis
• Various end-users who want to know more about the Airway Clearance Devices for Cystic Fibrosis Market and the latest technological developments in the Airway Clearance Devices for Cystic Fibrosis Market.

Frequently Asked Questions for the Airway Clearance Devices for Cystic Fibrosis Market:

1. What are Airway Clearance Devices for Cystic Fibrosis?

• Airway clearance devices for cystic fibrosis are specialized devices that mechanically aid in clearing thick, sticky mucus from the airways, thereby enhancing lung function and improving airways wall clearance.

2. What is the market for Airway Clearance Devices for Cystic Fibrosis?

• The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032.

3. What are the drivers for the global Airway Clearance Devices for Cystic Fibrosis market?

• The airway clearance devices for cystic fibrosis market is slated to witness prosperity owing to factors such as the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, research collaborations among key players are some of the key factors responsible for contributing to the positive growth of the airway clearance devices for cystic fibrosis market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global Airway Clearance Devices for Cystic Fibrosis market?

• Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

5. Which region has the highest share in the global Airway Clearance Devices For Cystic Fibrosis market?

• North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. Thus the rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.

Table of Contents

1. Airway Clearance Devices For Cystic Fibrosis Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Airway Clearance Devices For Cystic Fibrosis Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Airway Clearance Devices For Cystic Fibrosis Market Key Factors Analysis

• 5.1. Airway Clearance Devices For Cystic Fibrosis Market Drivers
  • 5.1.1. The growing prevalence of cystic fibrosis
  • 5.1.2. Increasing genetic disease cases
  • 5.1.3. Growing R&D activities and research collaboration among key players
• 5.2. Airway Clearance Devices For Cystic Fibrosis Market Restraints and Challenges
  • 5.2.1. Complications associated with airway clearance devices
  • 5.2.2. Product recalls
• 5.3. Airway Clearance Devices For Cystic Fibrosis Market Opportunity
  • 5.3.1. Integration of digital health for homecare settings
  • 5.3.2. Emergence of AI-enabled airway clearance devices

6. Airway Clearance Devices For Cystic Fibrosis Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Airway Clearance Devices For Cystic Fibrosis Market Assessment

• 7.1. By Device Type
  • 7.1.1. High Frequency Chest Wall Oscillation Device
  • 7.1.2. Positive Expiratory Pressure Devices
  • 7.1.3. Mechanical Percussion (MP) Devices
  • 7.1.4. Others
• 7.2. By End-User
  • 7.2.1. Hospitals and Clinics
  • 7.2.2. Home Healthcare
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.1.2. Canada Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.1.3. Mexico Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
  • 7.3.2. Europe
    • 7.3.2.1. France Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2.2. Germany Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2.3. United Kingdom Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2.4. Italy Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2.5. Spain Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2.6. Rest of Europe Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3.2. Japan Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3.3. India Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3.4. Australia Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3.5. South Korea Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3.6. Rest of Asia-Pacific Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.4.2. Africa Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.4.3. South America Airway Clearance Devices For Cystic Fibrosis Market Size In USD Million (2022-2032)

8. Airway Clearance Devices For Cystic Fibrosis Market Company and Product Profiles

• 8.1. Baxter
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Koninklijke Philips N.V.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Electromed, Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. ICU Medical, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Trudell Medical International
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. CEGLA Medizintechnik GmbH
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. PARI GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Monaghan
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. VORTRAN Medical Technology 1 Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Tactile Medical
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Mercury Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Med Systems, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Vyaire Medical, Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Synchrony Medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Dymedso
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. SunMed LLCWestmed, Inc.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. RespInnovation
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Inogen, Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Thayer Medical
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Medline Industries, LP
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us